[ Price : $8.95]
Two stakeholders respond to an FDA request for comments on the agencys recent listening session on advisory committees and their g...[ Price : $8.95]
Federal Register notice: FDA seeks comments on the abuse potential, medical usefulness, trafficking, and impact of scheduling chan...[ Price : $8.95]
Federal Register notice: FDA announces a 10/7 Science Board Advisory Committee meeting that will hear an update from the new Alter...[ Price : $8.95]
Two stakeholders call on FDA to make major changes to a draft guidance on the REMS logic model that is intended to link program de...[ Price : $8.95]
The drug development consulting firm Rahaa asks FDA to require stability studies under refrigerated conditions for generic version...[ Price : $8.95]
FDA gives accelerated approval to Gileads Livdelzi to treat some cases of primary biliary cholangitis.[ Price : $8.95]
After reporting preliminary positive results from a Phase 2 clinical trial studying VP-315 in basal cell carcinoma patients, Verri...